{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:21:36Z","timestamp":1790108496930,"version":"4.0.1"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-025-00781-y","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T03:21:49Z","timestamp":1757042509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Green tea\u2019s secret weapon: a review on the protective effects of epigallocatechin-3-gallate against ischemia\/reperfusion damage"],"prefix":"10.1007","author":[{"given":"Yingxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"781_CR1","doi-asserted-by":"crossref","unstructured":"Soares ROS, et al. Ischemia\/reperfusion injury revisited: an overview of the latest pharmacological strategies. Int J Mol Sci. 2019;20(20).","DOI":"10.3390\/ijms20205034"},{"issue":"1","key":"781_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Therapy. 2024;9(1):12.","journal-title":"Signal Transduct Target Therapy"},{"issue":"6","key":"781_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33(6):357\u201366.","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"781_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/biomedicines10030574","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A, Ardelean AI. Oxidative stress in ischemia\/reperfusion injuries following acute ischemic stroke. Biomedicines. 2022;10(3):574.","journal-title":"Biomedicines"},{"issue":"12","key":"781_CR5","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s11064-022-03697-8","volume":"47","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. Cell death mechanisms in cerebral ischemia\u2013reperfusion injury. Neurochem Res. 2022;47(12):3525\u201342.","journal-title":"Neurochem Res"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"Kalogeris T, et al. Cell biology of ischemia\/reperfusion injury. Int Rev Cell Mol Biology. 2012;298:229\u2013317.","journal-title":"Int Rev Cell Mol Biology"},{"issue":"2","key":"781_CR7","doi-asserted-by":"publisher","first-page":"S644","DOI":"10.1016\/S0003-4975(02)04686-6","volume":"75","author":"HM Piper","year":"2003","unstructured":"Piper HM, Meuter K, Sch\u00e4fer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg. 2003;75(2):S644\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"781_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0167-5273(02)00189-4","volume":"86","author":"KA Kaminski","year":"2002","unstructured":"Kaminski KA, et al. Oxidative stress and neutrophil activation\u2014the two keystones of ischemia\/reperfusion injury. Int J Cardiol. 2002;86(1):41\u201359.","journal-title":"Int J Cardiol"},{"issue":"1","key":"781_CR9","first-page":"590987","volume":"2015","author":"RS Ferrari","year":"2015","unstructured":"Ferrari RS, Andrade CF. Oxidative stress and lung ischemia-reperfusion injury. Oxidative Med Cell Longev. 2015;2015(1):590987.","journal-title":"Oxidative Med Cell Longev"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40472-014-0017-6","volume":"1","author":"BR Slegtenhorst","year":"2014","unstructured":"Slegtenhorst BR, et al. Ischemia\/reperfusion injury and its consequences on immunity and inflammation. Curr Transplantation Rep. 2014;1:147\u201354.","journal-title":"Curr Transplantation Rep"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-7-27","volume":"7","author":"J Lutz","year":"2010","unstructured":"Lutz J, Th\u00fcrmel K, Heemann U. Anti-inflammatory treatment strategies for ischemia\/reperfusion injury in transplantation. J Inflamm. 2010;7:1\u20138.","journal-title":"J Inflamm"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnmol.2020.00028","volume":"13","author":"L Wu","year":"2020","unstructured":"Wu L, et al. Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci. 2020;13:28.","journal-title":"Front Mol Neurosci"},{"issue":"34","key":"781_CR13","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.2174\/1381612825666181120155953","volume":"24","author":"K Pittas","year":"2018","unstructured":"Pittas K, et al. The role of calcium handling mechanisms in reperfusion injury. Curr Pharm Design. 2018;24(34):4077\u201389.","journal-title":"Curr Pharm Design"},{"issue":"67","key":"781_CR14","first-page":"pe70268","volume":"2025","author":"S Liu","year":"2020","unstructured":"Liu S, et al. Oxidative stress: signaling pathways, biological functions, and disease. MedComm. 2020;2025(67):pe70268.","journal-title":"MedComm"},{"issue":"12","key":"781_CR15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/aps.2010.186","volume":"31","author":"P-f Wu","year":"2010","unstructured":"Wu P-f, et al. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia\/reperfusion injury. Acta Pharmacol Sin. 2010;31(12):1523\u201331.","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"781_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/antiox12091760","volume":"12","author":"S Orellana-Urz\u00faa","year":"2023","unstructured":"Orellana-Urz\u00faa S, et al. Potential role of natural antioxidants in countering reperfusion injury in acute myocardial infarction and ischemic stroke. Antioxidants. 2023;12(9):1760.","journal-title":"Antioxidants"},{"issue":"17","key":"781_CR17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","volume":"67","author":"DG Nagle","year":"2006","unstructured":"Nagle DG, Ferreira D, Zhou Y-D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 2006;67(17):1849\u201355.","journal-title":"Phytochemistry"},{"issue":"4","key":"781_CR18","doi-asserted-by":"publisher","first-page":"S373","DOI":"10.1080\/07315724.2007.10719626","volume":"26","author":"S Wolfram","year":"2007","unstructured":"Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr. 2007;26(4):S373\u201388.","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"781_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3892\/ijmm.2016.2615","volume":"38","author":"F Xuan","year":"2016","unstructured":"Xuan F, Jian J. Epigallocatechin gallate exerts protective effects against myocardial ischemia\/reperfusion injury through the PI3K\/Akt pathway-mediated Inhibition of apoptosis and the restoration of the autophagic flux. Int J Mol Med. 2016;38(1):328\u201336.","journal-title":"Int J Mol Med"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2119\/2004-00032.Aneja","volume":"10","author":"R Aneja","year":"2004","unstructured":"Aneja R, et al. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004;10:55\u201362.","journal-title":"Mol Med"},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tifs.2021.05.023","volume":"114","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, et al. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol. 2021;114:11\u201324.","journal-title":"Trends Food Sci Technol"},{"key":"781_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actbio.2021.02.005","volume":"124","author":"S Lee","year":"2021","unstructured":"Lee S, et al. Evaluation of the anti-oxidative and ROS scavenging properties of biomaterials coated with Epigallocatechin gallate for tissue engineering. Acta Biomater. 2021;124:166\u201378.","journal-title":"Acta Biomater"},{"issue":"12","key":"781_CR23","doi-asserted-by":"publisher","first-page":"e23203","DOI":"10.1002\/jbt.23203","volume":"36","author":"M Di","year":"2022","unstructured":"Di M, et al. Epigallocatechin-3\u2010gallate (EGCG) attenuates inflammatory responses and oxidative stress in lipopolysaccharide (LPS)\u2010induced endometritis via silent information regulator transcript\u20101 (SIRT1)\/nucleotide oligomerization domain (NOD)\u2010like receptor Pyrin domain\u2010containing 3 (NLRP3) pathway. J Biochem Mol Toxicol. 2022;36(12):e23203.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"781_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms24010340","volume":"24","author":"D Mokra","year":"2022","unstructured":"Mokra D, Joskova M, Mokry J. Therapeutic effects of green tea polyphenol (\u2013)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. Int J Mol Sci. 2022;24(1):340.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"781_CR25","doi-asserted-by":"publisher","first-page":"155932582211057","DOI":"10.1177\/15593258221105704","volume":"20","author":"C He","year":"2022","unstructured":"He C, et al. Epigallocatechin gallate induces the demethylation of actinin alpha 4 to inhibit diabetic nephropathy renal fibrosis via the NF-KB signaling pathway in vitro. Dose-response. 2022;20(2):15593258221105704.","journal-title":"Dose-response"},{"issue":"14","key":"781_CR26","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1080\/07391102.2020.1785946","volume":"39","author":"SB Varthya","year":"2021","unstructured":"Varthya SB, et al. Efficacy of green tea, its polyphenols and nanoformulation in experimental colitis and the role of non-canonical and canonical nuclear factor kappa beta (NF-kB) pathway: a preclinical in-vivo and in-silico exploratory study. J Biomol Struct Dynamics. 2021;39(14):5314\u201326.","journal-title":"J Biomol Struct Dynamics"},{"key":"781_CR27","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu Q, et al. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine. 2023;119:154999.","journal-title":"Phytomedicine"},{"issue":"4","key":"781_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/jbcpp-2020-0454","volume":"32","author":"A Machin","year":"2021","unstructured":"Machin A, Susilo I, Purwanto DA. Green tea and its active compound epigallocathechin-3-gallate (EGCG) inhibit neuronal apoptosis in a middle cerebral artery occlusion (MCAO) model. J Basic Clin Physiol Pharmacol. 2021;32(4):319\u201325.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"12","key":"781_CR29","first-page":"1325","volume":"46","author":"F He","year":"2021","unstructured":"He F, et al. Effect of EGCG on inflammatory reaction in rats suffered cerebral ischemia\/reperfusion injury. Zhong Nan Da Xue Xue bao. Yi Xue ban\u2009=\u2009journal of central South university. Med Sci. 2021;46(12):1325\u201331.","journal-title":"Med Sci"},{"key":"781_CR30","doi-asserted-by":"publisher","first-page":"921394","DOI":"10.3389\/fphar.2022.921394","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, et al. EGCG protects the mouse brain against cerebral ischemia\/reperfusion injury by suppressing autophagy via the akt\/ampk\/mtor phosphorylation pathway. Front Pharmacol. 2022;13:921394.","journal-title":"Front Pharmacol"},{"issue":"1","key":"781_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s43556-024-00240-9","volume":"5","author":"M Alam","year":"2024","unstructured":"Alam M, et al. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Mol Biomed. 2024;5(1):73.","journal-title":"Mol Biomed"},{"issue":"1","key":"781_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1878-5085-4-5","volume":"4","author":"A M\u00e4hler","year":"2013","unstructured":"M\u00e4hler A, et al. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? Epma J. 2013;4(1):5.","journal-title":"Epma J"},{"issue":"5","key":"781_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1159\/000453170","volume":"40","author":"H-b Wang","year":"2016","unstructured":"Wang H-b, et al. RNAi-mediated down-regulation of CD47 protects against ischemia\/reperfusion-induced myocardial damage via activation of eNOS in a rat model. Cell Physiol Biochem. 2016;40(5):1163\u201374.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"781_CR34","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/ijms18102034","volume":"18","author":"M-Y Wu","year":"2017","unstructured":"Wu M-Y, et al. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 2017;18(10):2034.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"781_CR35","doi-asserted-by":"publisher","first-page":"105103","DOI":"10.1016\/j.jbc.2023.105103","volume":"299","author":"D Flood","year":"2023","unstructured":"Flood D, Lee ES, Taylor CT. Intracellular energy production and distribution in hypoxia. J Biol Chem. 2023;299(9):105103.","journal-title":"J Biol Chem"},{"issue":"1","key":"781_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu H, et al. Energy metabolism in health and diseases. Signal Transduct Target Ther. 2025;10(1):69.","journal-title":"Signal Transduct Target Ther"},{"key":"781_CR37","doi-asserted-by":"publisher","first-page":"1150171","DOI":"10.3389\/fendo.2023.1150171","volume":"14","author":"M Obradovic","year":"2023","unstructured":"Obradovic M, et al. The Na(+)\/K(+)-ATPase: A potential therapeutic target in cardiometabolic diseases. Front Endocrinol (Lausanne). 2023;14:1150171.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"781_CR38","doi-asserted-by":"publisher","first-page":"100254","DOI":"10.1016\/j.mocell.2025.100254","volume":"48","author":"H-O Gu","year":"2025","unstructured":"Gu H-O, et al. Crucial roles of calcium ATPases and phosphoinositides: insights into pathophysiology and therapeutic strategies. Mol Cells. 2025;48(9):100254.","journal-title":"Mol Cells"},{"issue":"6","key":"781_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1113\/jphysiol.2014.282319","volume":"593","author":"MJ Shattock","year":"2015","unstructured":"Shattock MJ, et al. Na+\/Ca2\u2009+\u2009exchange and Na+\/K+-ATPase in the heart. J Physiol. 2015;593(6):1361\u201382.","journal-title":"J Physiol"},{"issue":"Pt 3","key":"781_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1469-7793.2001.0405k.x","volume":"530","author":"D Willoughby","year":"2001","unstructured":"Willoughby D, Thomas R, Schwiening C. The effects of intracellular pH changes on resting cytosolic calcium in voltage-clamped snail neurones. J Physiol. 2001;530(Pt 3):405\u201316.","journal-title":"J Physiol"},{"key":"781_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","volume":"6","author":"DN Granger","year":"2015","unstructured":"Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 2015;6:524\u201351.","journal-title":"Redox Biol"},{"key":"781_CR42","doi-asserted-by":"crossref","unstructured":"Jurcau A, Ardelean AI. Oxidative stress in ischemia\/reperfusion injuries following acute ischemic stroke. Biomedicines. 2022;10(3).","DOI":"10.3390\/biomedicines10030574"},{"issue":"5","key":"781_CR43","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1159\/000471866","volume":"41","author":"FM Ornellas","year":"2017","unstructured":"Ornellas FM, et al. Bone marrow\u2013derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory, antioxidant and apoptotic related molecules. Cell Physiol Biochem. 2017;41(5):1736\u201352.","journal-title":"Cell Physiol Biochem"},{"key":"781_CR44","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.biopha.2018.11.128","volume":"111","author":"N Koju","year":"2019","unstructured":"Koju N, et al. Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria. Biomed Pharmacother. 2019;111:1478\u201398.","journal-title":"Biomed Pharmacother"},{"key":"781_CR45","doi-asserted-by":"publisher","first-page":"1000578","DOI":"10.3389\/fcvm.2022.1000578","volume":"9","author":"R Miao","year":"2022","unstructured":"Miao R, et al. Advances in the study of nicotinamide adenine dinucleotide phosphate oxidase in myocardial remodeling. Front Cardiovasc Med. 2022;9:1000578.","journal-title":"Front Cardiovasc Med"},{"key":"781_CR46","doi-asserted-by":"crossref","unstructured":"Perkins K-AA, et al. The effects of modulating eNOS activity and coupling in ischemia\/reperfusion (I\/R). Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2012;385:27\u201338.","DOI":"10.1007\/s00210-011-0693-z"},{"issue":"14","key":"781_CR47","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.107.725481","volume":"117","author":"AL Moens","year":"2008","unstructured":"Moens AL, et al. High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation. 2008;117(14):1810\u20139.","journal-title":"Circulation"},{"issue":"22","key":"781_CR48","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1021\/bi500076r","volume":"53","author":"F De Pascali","year":"2014","unstructured":"De Pascali F, et al. Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry. 2014;53(22):3679\u201388.","journal-title":"Biochemistry"},{"issue":"35","key":"781_CR49","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.2174\/0929867323666160725091915","volume":"23","author":"MG Battelli","year":"2016","unstructured":"Battelli MG, et al. Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme. Curr Med Chem. 2016;23(35):4027\u201336.","journal-title":"Curr Med Chem"},{"key":"781_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, et al. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8\u201314.","journal-title":"Int J Cardiol"},{"issue":"1","key":"781_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther. 2021;6(1):162.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"781_CR52","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s40262-022-01164-9","volume":"61","author":"WY Chu","year":"2022","unstructured":"Chu WY, et al. Semi-mechanistic modeling of hypoxanthine, xanthine, and uric acid metabolism in asphyxiated neonates. Clin Pharmacokinet. 2022;61(11):1545\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"781_CR53","doi-asserted-by":"publisher","first-page":"p1470380","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, et al. The role of oxidative stress in hyperuricemia and Xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev. 2021;2021:p1470380.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"781_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.redox.2013.05.002","volume":"1","author":"N Cantu-Medellin","year":"2013","unstructured":"Cantu-Medellin N, Kelley EE. Xanthine oxidoreductase-catalyzed reactive species generation: a process in critical need of reevaluation. Redox Biol. 2013;1(1):353\u20138.","journal-title":"Redox Biol"},{"key":"781_CR55","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti M, et al. Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol. 2021;41:101882.","journal-title":"Redox Biol"},{"issue":"3","key":"781_CR56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/ars.1999.1.3-371","volume":"1","author":"SA Sanders","year":"1999","unstructured":"Sanders SA, Massey V. The thermodynamics of Xanthine oxidoreductase catalysis. Antioxid Redox Signal. 1999;1(3):371\u20139.","journal-title":"Antioxid Redox Signal"},{"key":"781_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11357-997-0012-2","volume":"20","author":"HY Chung","year":"1997","unstructured":"Chung HY, et al. Xanthine dehydrogenase\/xanthine oxidase and oxidative stress. Age. 1997;20:127\u201340.","journal-title":"Age"},{"issue":"41","key":"781_CR58","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1021\/bi500582r","volume":"53","author":"MC Lee","year":"2014","unstructured":"Lee MC, et al. Measurement and characterization of superoxide generation from Xanthine dehydrogenase: a redox-regulated pathway of radical generation in ischemic tissues. Biochemistry. 2014;53(41):6615\u201323.","journal-title":"Biochemistry"},{"issue":"6 Pt 2","key":"781_CR59","first-page":"H1269","volume":"255","author":"DN Granger","year":"1988","unstructured":"Granger DN. Role of Xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988;255(6 Pt 2):H1269\u201375.","journal-title":"Am J Physiol"},{"issue":"41","key":"781_CR60","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1021\/bi500582r","volume":"53","author":"M-C-i Lee","year":"2014","unstructured":"Lee M-C-i, et al. Measurement and characterization of superoxide generation from Xanthine dehydrogenase: a redox-regulated pathway of radical generation in ischemic tissues. Biochemistry. 2014;53(41):6615\u201323.","journal-title":"Biochemistry"},{"issue":"1","key":"781_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause K-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245\u2013313.","journal-title":"Physiol Rev"},{"issue":"17","key":"781_CR62","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1089\/ars.2013.5603","volume":"20","author":"JL Meitzler","year":"2014","unstructured":"Meitzler JL, et al. NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal. 2014;20(17):2873\u201389.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"781_CR63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/ATVBAHA.108.181610","volume":"30","author":"B Lass\u00e8gue","year":"2010","unstructured":"Lass\u00e8gue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol. 2010;30(4):653\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"781_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","volume":"76","author":"RP Brandes","year":"2014","unstructured":"Brandes RP, Weissmann N, Schr\u00f6der K. Nox family NADPH oxidases: molecular mechanisms of activation. Free Radic Biol Med. 2014;76:208\u201326.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"781_CR65","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1681\/ASN.2012111112","volume":"24","author":"M Sedeek","year":"2013","unstructured":"Sedeek M, et al. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24(10):1512\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"Supplement2","key":"781_CR66","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2337\/dc08-s247","volume":"31","author":"TM Paravicini","year":"2008","unstructured":"Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(Supplement2):S170\u201380.","journal-title":"Diabetes Care"},{"issue":"11","key":"781_CR67","doi-asserted-by":"publisher","first-page":"8123","DOI":"10.1167\/iovs.11-8318","volume":"52","author":"H Yokota","year":"2011","unstructured":"Yokota H, et al. Neuroprotection from retinal ischemia\/reperfusion injury by NOX2 NADPH oxidase deletion. Investig Ophthalmol Vis Sci. 2011;52(11):8123\u201331.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"781_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2014.07.003","volume":"74","author":"S Simone","year":"2014","unstructured":"Simone S, et al. Complement-dependent NADPH oxidase enzyme activation in renal ischemia\/reperfusion injury. Free Radic Biol Med. 2014;74:263\u201373.","journal-title":"Free Radic Biol Med"},{"key":"781_CR69","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10787-007-1587-z","volume":"15","author":"A Nakagiri","year":"2007","unstructured":"Nakagiri A, Sunamoto M, Murakami M. NADPH oxidase is involved in ischaemia\/reperfusion-induced damage in rat gastric mucosa via ROS production\u2013role of NADPH oxidase in rat stomachs. Inflammopharmacology. 2007;15:278\u201381.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"781_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2006.06.082","volume":"1111","author":"AA Miller","year":"2006","unstructured":"Miller AA, et al. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res. 2006;1111(1):111\u20136.","journal-title":"Brain Res"},{"key":"781_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0150-7","volume":"12","author":"MW Ma","year":"2017","unstructured":"Ma MW, et al. NADPH oxidase in brain injury and neurodegenerative disorders. Mol Neurodegeneration. 2017;12:1\u201328.","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"781_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315\u2013424.","journal-title":"Physiol Rev"},{"issue":"6","key":"781_CR73","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/antiox10060890","volume":"10","author":"A Vermot","year":"2021","unstructured":"Vermot A, NADPH Oxidases (NOX), et al. An overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants. 2021;10(6):890.","journal-title":"Antioxidants"},{"key":"781_CR74","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.redox.2017.09.009","volume":"14","author":"S Bartesaghi","year":"2018","unstructured":"Bartesaghi S, Radi R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 2018;14:618\u201325.","journal-title":"Redox Biol"},{"key":"781_CR75","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.redox.2019.101109","volume":"25","author":"HS Li","year":"2019","unstructured":"Li HS, et al. HIF-1\u03b1 protects against oxidative stress by directly targeting mitochondria. Redox Biol. 2019;25:101109.","journal-title":"Redox Biol"},{"issue":"11","key":"781_CR76","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/jcp.22640","volume":"226","author":"G Yuan","year":"2011","unstructured":"Yuan G, et al. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol. 2011;226(11):2925\u201333.","journal-title":"J Cell Physiol"},{"key":"781_CR77","doi-asserted-by":"publisher","first-page":"1219316","DOI":"10.3389\/fcvm.2023.1219316","volume":"10","author":"W Luo","year":"2023","unstructured":"Luo W, et al. A new method for the treatment of myocardial ischemia-reperfusion injury based on \u03b3\u03b4T cell-mediated immune response. Front Cardiovasc Med. 2023;10:1219316.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"781_CR78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.freeradbiomed.2011.06.003","volume":"51","author":"PA Fraser","year":"2011","unstructured":"Fraser PA. The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med. 2011;51(5):967\u201377.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"781_CR79","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6","volume":"190","author":"DL Carden","year":"2000","unstructured":"Carden DL, Granger DN. Pathophysiology of ischaemia\u2013reperfusion injury. J Pathol. 2000;190(3):255\u201366.","journal-title":"J Pathol"},{"key":"781_CR80","doi-asserted-by":"crossref","unstructured":"Dewald B, Baggiolini M. Activation of NADPH oxidase in human neutrophils: synergism between fMLP and the neutrophil products PAF and LTB4. Biochemi Biophysi Res Commun. 1985;128(1):297\u2013304.","DOI":"10.1016\/0006-291X(85)91678-X"},{"key":"781_CR81","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1007\/BF02063228","volume":"40","author":"N Yoshida","year":"1995","unstructured":"Yoshida N, et al. Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury. Dig Dis Sci. 1995;40:2300\u20134.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"781_CR82","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/ki.1995.451","volume":"48","author":"SL Linas","year":"1995","unstructured":"Linas SL, et al. Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and ICAM 1. Kidney Int. 1995;48(5):1584\u201391.","journal-title":"Kidney Int"},{"issue":"2","key":"781_CR83","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0022-3565(25)21794-3","volume":"228","author":"KM Mullane","year":"1984","unstructured":"Mullane KM, et al. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther. 1984;228(2):510\u201322.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"781_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cvr\/23.4.323","volume":"23","author":"T Kuzuya","year":"1989","unstructured":"Kuzuya T, et al. Role of free radicals and neutrophils in canine myocardial reperfusion injury: myocardial salvage by a novel free radical scavenger, 2-octadecylascorbic acid. Cardiovascular Res. 1989;23(4):323\u201330.","journal-title":"Cardiovascular Res"},{"issue":"3","key":"781_CR85","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cardiores.2006.09.012","volume":"72","author":"HS Park","year":"2006","unstructured":"Park HS, et al. Role of NADPH oxidase 4 in lipopolysaccharide-induced Proinflammatory responses by human aortic endothelial cells. Cardiovascular Res. 2006;72(3):447\u201355.","journal-title":"Cardiovascular Res"},{"issue":"2","key":"781_CR86","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.mcn.2009.03.007","volume":"41","author":"BM Barth","year":"2009","unstructured":"Barth BM, Stewart-Smeets S, Kuhn TB. Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol Cell Neurosci. 2009;41(2):274\u201385.","journal-title":"Mol Cell Neurosci"},{"issue":"1\u20133","key":"781_CR87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-2999(03)01315-3","volume":"462","author":"A Oudot","year":"2003","unstructured":"Oudot A, et al. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia\u2013reperfusion. Eur J Pharmacol. 2003;462(1\u20133):145\u201354.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"781_CR88","first-page":"171","volume":"61","author":"A Nakagiri","year":"2010","unstructured":"Nakagiri A, et al. Evidence for the involvement of NADPH oxidase in ischemia\/reperfusion-induced gastric damage via angiotensin II. J Physiol Pharmacol. 2010;61(2):171.","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"781_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28(1):51.","journal-title":"Cell Mol Biol Lett"},{"key":"781_CR90","doi-asserted-by":"crossref","unstructured":"Wang H et al. NLRP3 inflammasome in health and disease (Review). Int J Mol Med. 2025;55(3).","DOI":"10.3892\/ijmm.2025.5489"},{"issue":"4","key":"781_CR91","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5114\/biolsport.2021.99323","volume":"38","author":"F Koji\u0107","year":"2021","unstructured":"Koji\u0107 F, et al. Effects of resistance training on hypertrophy, strength and tensiomyography parameters of elbow flexors: role of eccentric phase duration. Biol Sport. 2021;38(4):587\u201394.","journal-title":"Biol Sport"},{"key":"781_CR92","doi-asserted-by":"publisher","first-page":"831005","DOI":"10.3389\/fmed.2022.831005","volume":"9","author":"A Faron","year":"2022","unstructured":"Faron A, et al. Combination of Fat-Free muscle index and total spontaneous portosystemic shunt area identifies High-Risk cirrhosis patients. Front Med (Lausanne). 2022;9:831005.","journal-title":"Front Med (Lausanne)"},{"key":"781_CR93","doi-asserted-by":"publisher","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022;236:108053.","journal-title":"Pharmacol Ther"},{"issue":"13","key":"781_CR94","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","volume":"113","author":"U Forstermann","year":"2006","unstructured":"Forstermann U, M\u00fcnzel T. Endothelial nitric oxide synthase in vascular disease: from Marvel to menace. Circulation. 2006;113(13):1708\u201314.","journal-title":"Circulation"},{"issue":"7","key":"781_CR95","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829\u201337.","journal-title":"Eur Heart J"},{"issue":"1","key":"781_CR96","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/08941930802709470","volume":"22","author":"L Phillips","year":"2009","unstructured":"Phillips L, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22(1):46\u201355.","journal-title":"J Invest Surg"},{"issue":"3","key":"781_CR97","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/01.RES.74.3.376","volume":"74","author":"I Kurose","year":"1994","unstructured":"Kurose I, et al. Modulation of ischemia\/reperfusion-induced microvascular dysfunction by nitric oxide. Circul Res. 1994;74(3):376\u201382.","journal-title":"Circul Res"},{"key":"781_CR98","doi-asserted-by":"crossref","unstructured":"Granata S et al. Oxidative stress and ischemia\/reperfusion injury in kidney transplantation: focus on ferroptosis, mitophagy and new antioxidants. Antioxid (Basel). 2022;11(4).","DOI":"10.3390\/antiox11040769"},{"issue":"2","key":"781_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.niox.2011.04.004","volume":"25","author":"MJ Crabtree","year":"2011","unstructured":"Crabtree MJ, Channon KM. Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitric Oxide. 2011;25(2):81\u20138.","journal-title":"Nitric Oxide"},{"issue":"20","key":"781_CR100","doi-asserted-by":"publisher","first-page":"13660","DOI":"10.1074\/jbc.M807959200","volume":"284","author":"AL Tatham","year":"2009","unstructured":"Tatham AL, et al. GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression. J Biol Chem. 2009;284(20):13660\u20138.","journal-title":"J Biol Chem"},{"issue":"5","key":"781_CR101","doi-asserted-by":"publisher","first-page":"E481","DOI":"10.1152\/ajpendo.00540.2011","volume":"302","author":"R Kietadisorn","year":"2012","unstructured":"Kietadisorn R, Juni RP, Moens AL. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiology-Endocrinology Metabolism. 2012;302(5):E481\u201395.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"3","key":"781_CR102","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","volume":"140","author":"L Rochette","year":"2013","unstructured":"Rochette L, et al. Nitric oxide synthase Inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther. 2013;140(3):239\u201357.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"781_CR103","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tips.2008.10.003","volume":"30","author":"ZS Katusic","year":"2009","unstructured":"Katusic ZS, d\u2019Uscio LV, Nath KA. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci. 2009;30(1):48\u201354.","journal-title":"Trends Pharmacol Sci"},{"issue":"18","key":"781_CR104","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1089\/ars.2013.5566","volume":"20","author":"JK Bendall","year":"2014","unstructured":"Bendall JK, et al. Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox Signal. 2014;20(18):3040\u201377.","journal-title":"Antioxid Redox Signal"},{"key":"781_CR105","doi-asserted-by":"publisher","first-page":"720632","DOI":"10.3389\/fonc.2021.720632","volume":"11","author":"Y Feng","year":"2021","unstructured":"Feng Y, et al. The critical role of tetrahydrobiopterin (BH4) metabolism in modulating radiosensitivity: BH4\/NOS axis as an Angel or a devil. Front Oncol. 2021;11:720632.","journal-title":"Front Oncol"},{"issue":"1\u20133","key":"781_CR106","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/ars.2021.0136","volume":"37","author":"J Vasquez-Vivar","year":"2022","unstructured":"Vasquez-Vivar J, Shi Z, Tan S. Tetrahydrobiopterin in cell function and death mechanisms. Antioxid Redox Signal. 2022;37(1\u20133):171\u201383.","journal-title":"Antioxid Redox Signal"},{"key":"781_CR107","doi-asserted-by":"crossref","unstructured":"Zhang Y, Jiang M, Wang T. Reactive oxygen species (ROS)-responsive biomaterials for treating myocardial ischemia-reperfusion injury. Front Bioeng Biotechnol. 2024;12.","DOI":"10.3389\/fbioe.2024.1469393"},{"issue":"3\u20134","key":"781_CR108","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1074248411409581","volume":"16","author":"RA Gottlieb","year":"2011","unstructured":"Gottlieb RA. Cell death pathways in acute ischemia\/reperfusion injury. J Cardiovasc Pharmacol Therap. 2011;16(3\u20134):233\u20138.","journal-title":"J Cardiovasc Pharmacol Therap"},{"issue":"6","key":"781_CR109","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/08941930500328862","volume":"18","author":"F Lopez-Neblina","year":"2005","unstructured":"Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg. 2005;18(6):335\u201350.","journal-title":"J Invest Surg"},{"issue":"3","key":"781_CR110","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cardiores.2003.12.023","volume":"61","author":"F Eefting","year":"2004","unstructured":"Eefting F, et al. Role of apoptosis in reperfusion injury. Cardiovascular Res. 2004;61(3):414\u201326.","journal-title":"Cardiovascular Res"},{"key":"781_CR111","doi-asserted-by":"crossref","unstructured":"McCully JD, et al. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2004;286(5):H1923-H1935.","DOI":"10.1152\/ajpheart.00935.2003"},{"issue":"3","key":"781_CR112","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1159\/000485401","volume":"44","author":"H Liu","year":"2017","unstructured":"Liu H, et al. Overexpression of TIMP3 protects against cardiac ischemia\/reperfusion injury by inhibiting myocardial apoptosis through ros\/mapks pathway. Cell Physiol Biochem. 2017;44(3):1011\u201323.","journal-title":"Cell Physiol Biochem"},{"key":"781_CR113","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.redox.2014.05.006","volume":"2","author":"T Kalogeris","year":"2014","unstructured":"Kalogeris T, Bao Y, Korthuis RJ. Mitochondrial reactive oxygen species: a double edged sword in ischemia\/reperfusion vs preconditioning. Redox Biol. 2014;2:702\u201314.","journal-title":"Redox Biol"},{"issue":"11","key":"781_CR114","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1111\/jcmm.13330","volume":"21","author":"C Maneechote","year":"2017","unstructured":"Maneechote C, et al. Roles of mitochondrial dynamics modulators in cardiac ischaemia\/reperfusion injury. J Cell Mol Med. 2017;21(11):2643\u201353.","journal-title":"J Cell Mol Med"},{"issue":"39","key":"781_CR115","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.2174\/138161281939131127110701","volume":"19","author":"L Calo","year":"2013","unstructured":"Calo L, et al. Mitochondrial dynamics: an emerging paradigm in ischemia-reperfusion injury. Curr Pharm Design. 2013;19(39):6848\u201357.","journal-title":"Curr Pharm Design"},{"issue":"2","key":"781_CR116","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cardiores.2006.01.016","volume":"70","author":"F Di Lisa","year":"2006","unstructured":"Di Lisa F, Bernardi P. Mitochondria and ischemia\u2013reperfusion injury of the heart: fixing a hole. Cardiovascular Res. 2006;70(2):191\u20139.","journal-title":"Cardiovascular Res"},{"issue":"11","key":"781_CR117","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1111\/ajt.12448","volume":"13","author":"A Linkermann","year":"2013","unstructured":"Linkermann A, et al. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant. 2013;13(11):2797\u2013804.","journal-title":"Am J Transplant"},{"issue":"5","key":"781_CR118","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/02713683.2016.1227449","volume":"42","author":"CR Kim","year":"2017","unstructured":"Kim CR, et al. Ischemia reperfusion injury triggers TNF\u03b1 induced-necroptosis in rat retina. Curr Eye Res. 2017;42(5):771\u20139.","journal-title":"Curr Eye Res"},{"issue":"9","key":"781_CR119","doi-asserted-by":"publisher","first-page":"e0184752","DOI":"10.1371\/journal.pone.0184752","volume":"12","author":"WK Saeed","year":"2017","unstructured":"Saeed WK, et al. Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury? PLoS ONE. 2017;12(9):e0184752.","journal-title":"PLoS ONE"},{"issue":"3","key":"781_CR120","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/cdd.2009.178","volume":"17","author":"WW Wong","year":"2010","unstructured":"Wong WW, et al. RIPK1 is not essential for TNFR1-induced activation of NF-\u03baB. Cell Death Differ. 2010;17(3):482\u20137.","journal-title":"Cell Death Differ"},{"issue":"4","key":"781_CR121","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1053\/j.ajkd.2015.05.021","volume":"66","author":"J-P Decuypere","year":"2015","unstructured":"Decuypere J-P, et al. Autophagy and the kidney: implications for ischemia-reperfusion injury and therapy. Am J Kidney Dis. 2015;66(4):699\u2013709.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"781_CR122","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4161\/auto.5655","volume":"4","author":"\u00c5B Gustafsson","year":"2008","unstructured":"Gustafsson \u00c5B, Gottlieb RA. Eat your heart out: role of autophagy in myocardial ischemia\/reperfusion. Autophagy. 2008;4(4):416\u201321.","journal-title":"Autophagy"},{"issue":"2","key":"781_CR123","first-page":"271","volume":"1852","author":"S Ma","year":"2015","unstructured":"Ma S, et al. The role of the autophagy in myocardial ischemia\/reperfusion injury. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2015;1852(2):271\u20136.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"1","key":"781_CR124","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41420-021-00726-3","volume":"7","author":"L Wang","year":"2021","unstructured":"Wang L, et al. GSK-3\u03b2 manipulates ferroptosis sensitivity by dominating iron homeostasis. Cell Death Discov. 2021;7(1):334.","journal-title":"Cell Death Discov"},{"issue":"4","key":"781_CR125","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1203\/00006450-200010000-00023","volume":"48","author":"F Groenendaal","year":"2000","unstructured":"Groenendaal F, et al. Effects of deferoxamine, a chelator of free iron, on NA(+), K(+)-ATPase activity of cortical brain cell membrane during early reperfusion after hypoxia-ischemia in newborn lambs. Pediatr Res. 2000;48(4):560\u20134.","journal-title":"Pediatr Res"},{"issue":"1","key":"781_CR126","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","volume":"5","author":"D Li","year":"2020","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 2020;5(1):108.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"781_CR127","doi-asserted-by":"publisher","first-page":"220","DOI":"10.24272\/j.issn.2095-8137.2020.042","volume":"41","author":"HF Yan","year":"2020","unstructured":"Yan HF, et al. The pathological role of ferroptosis in ischemia\/reperfusion-related injury. Zool Res. 2020;41(3):220\u201330.","journal-title":"Zool Res"},{"key":"781_CR128","doi-asserted-by":"crossref","unstructured":"Li Y, Cheng L, Li M. Effects of green tea extract epigallocatechin-3-gallate on oral diseases: a narrative review. Pathogens. 2024;13(8).","DOI":"10.3390\/pathogens13080634"},{"key":"781_CR129","doi-asserted-by":"crossref","unstructured":"Capasso L, et al. Epigallocatechin gallate (EGCG): pharmacological properties, biological activities and therapeutic potential. Molecules. 2025;30(3).","DOI":"10.3390\/molecules30030654"},{"issue":"1","key":"781_CR130","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.abb.2010.06.013","volume":"501","author":"JD Lambert","year":"2010","unstructured":"Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys. 2010;501(1):65\u201372.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"781_CR131","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imr.2013.12.001","volume":"3","author":"K-j Min","year":"2014","unstructured":"Min K-j, Kwon TK. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res. 2014;3(1):16\u201324.","journal-title":"Integr Med Res"},{"issue":"4","key":"781_CR132","first-page":"735","volume":"15","author":"KR Landis-Piwowar","year":"2005","unstructured":"Landis-Piwowar KR, et al. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs. Int J Mol Med. 2005;15(4):735\u201342.","journal-title":"Int J Mol Med"},{"issue":"16","key":"781_CR133","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1021\/jo401027r","volume":"78","author":"A Khandelwal","year":"2013","unstructured":"Khandelwal A, Hall JA, Blagg BS. Synthesis and structure\u2013activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor. J Org Chem. 2013;78(16):7859\u201384.","journal-title":"J Org Chem"},{"issue":"3","key":"781_CR134","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bbrc.2003.09.066","volume":"310","author":"S Matsubara","year":"2003","unstructured":"Matsubara S, et al. Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem Biophys Res Commun. 2003;310(3):715\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"781_CR135","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-2000-8599","volume":"66","author":"M Zhu","year":"2000","unstructured":"Zhu M, Chen Y, Li RC. Oral absorption and bioavailability of tea catechins. Planta Med. 2000;66(5):444\u20137.","journal-title":"Planta Med"},{"issue":"6","key":"781_CR136","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3177\/jnsv.43.679","volume":"43","author":"K Nakagawa","year":"1997","unstructured":"Nakagawa K, Miyazawa T. Absorption and distribution of tea catechin,(-)-epigallocatechin-3-gallate, in the rat. J Nutri Sci Vitaminol. 1997;43(6):679\u201384.","journal-title":"J Nutri Sci Vitaminol"},{"issue":"9","key":"781_CR137","first-page":"1045","volume":"25","author":"L Chen","year":"1997","unstructured":"Chen L, et al. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab Dispos. 1997;25(9):1045\u201350.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"781_CR138","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10915810305101","volume":"22","author":"RR Swezey","year":"2003","unstructured":"Swezey RR, et al. Absorption, tissue distribution and elimination of 4-[3H]-epigallocatechin gallate in beagle dogs. Int J Toxicol. 2003;22(3):187\u201393.","journal-title":"Int J Toxicol"},{"issue":"10","key":"781_CR139","first-page":"1025","volume":"11","author":"M-J Lee","year":"2002","unstructured":"Lee M-J, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (\u2013)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev. 2002;11(10):1025\u201332.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"781_CR140","first-page":"3312","volume":"9","author":"HS Chow","year":"2003","unstructured":"Chow HS, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of Epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9(9):3312\u20139.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"781_CR141","doi-asserted-by":"publisher","first-page":"S1619","DOI":"10.3945\/ajcn.113.058958","volume":"98","author":"MN Clifford","year":"2013","unstructured":"Clifford MN, van der Hooft JJ, Crozier A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols123. Am J Clin Nutr. 2013;98(6):S1619\u201330.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"781_CR142","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/molecules30030654","volume":"30","author":"L Capasso","year":"2025","unstructured":"Capasso L, et al. Epigallocatechin gallate (EGCG): Pharmacological properties, biological activities and therapeutic potential. Molecules. 2025;30(3):654.","journal-title":"Molecules"},{"issue":"12","key":"781_CR143","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/00498250110079149","volume":"31","author":"J Van Amelsvoort","year":"2001","unstructured":"Van Amelsvoort J, et al. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica. 2001;31(12):891\u2013901.","journal-title":"Xenobiotica"},{"key":"781_CR144","doi-asserted-by":"crossref","unstructured":"Andreu-Fern\u00e1ndez V, et al. Bioavailability of epigallocatechin gallate administered with different nutritional strategies in healthy volunteers. Antioxid (Basel). 2020;9(5).","DOI":"10.3390\/antiox9050440"},{"issue":"9","key":"781_CR145","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/ijms12095592","volume":"12","author":"D Mereles","year":"2011","unstructured":"Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci. 2011;12(9):5592\u2013603.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"781_CR146","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/carcin\/bgn182","volume":"29","author":"JD Lambert","year":"2008","unstructured":"Lambert JD, et al. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Carcinogenesis. 2008;29(10):2019\u201324.","journal-title":"Carcinogenesis"},{"issue":"13","key":"781_CR147","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.3390\/ijms241310737","volume":"24","author":"V Mar\u00edn","year":"2023","unstructured":"Mar\u00edn V, et al. The potential role of Epigallocatechin-3-Gallate (EGCG) in breast cancer treatment. Int J Mol Sci. 2023;24(13):10737.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"781_CR148","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","volume":"82","author":"BN Singh","year":"2011","unstructured":"Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82(12):1807\u201321.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"781_CR149","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phrs.2011.02.007","volume":"64","author":"S Sang","year":"2011","unstructured":"Sang S, et al. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64(2):87\u201399.","journal-title":"Pharmacol Res"},{"issue":"2","key":"781_CR150","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1271\/bbb.63.430","volume":"63","author":"K Okushio","year":"1999","unstructured":"Okushio K, et al. Methylation of tea catechins by rat liver homogenates. Biosci Biotechnol Biochem. 1999;63(2):430\u20132.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"6","key":"781_CR151","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1021\/mp700075m","volume":"4","author":"JD Lambert","year":"2007","unstructured":"Lambert JD, Sang S, Yang CS. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm. 2007;4(6):819\u201325.","journal-title":"Mol Pharm"},{"issue":"7","key":"781_CR152","first-page":"2519","volume":"30","author":"SD Rao","year":"2010","unstructured":"Rao SD, Pagidas K. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Res. 2010;30(7):2519\u201323.","journal-title":"Anticancer Res"},{"issue":"3","key":"781_CR153","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/ars.2007.1740","volume":"10","author":"N Khan","year":"2008","unstructured":"Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal. 2008;10(3):475\u2013510.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"781_CR154","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","volume":"66","author":"N Khan","year":"2006","unstructured":"Khan N, et al. Targeting multiple signaling pathways by green tea polyphenol (\u2013)-epigallocatechin-3-gallate. Cancer Res. 2006;66(5):2500\u20135.","journal-title":"Cancer Res"},{"issue":"6","key":"781_CR155","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1535-7163.MCT-06-0053","volume":"5","author":"F Spinella","year":"2006","unstructured":"Spinella F, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther. 2006;5(6):1483\u201392.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"781_CR156","doi-asserted-by":"publisher","first-page":"S3262","DOI":"10.1093\/jn\/133.10.3262S","volume":"133","author":"JD Lambert","year":"2003","unstructured":"Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133(10):S3262\u20137.","journal-title":"J Nutr"},{"key":"781_CR157","doi-asserted-by":"publisher","first-page":"p925640","DOI":"10.1155\/2015\/925640","volume":"2015","author":"AH Rahmani","year":"2015","unstructured":"Rahmani AH, et al. Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway. Biomed Res Int. 2015;2015:p925640.","journal-title":"Biomed Res Int"},{"issue":"7","key":"781_CR158","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/lt.21127","volume":"13","author":"M Jimenez-Saenz","year":"2007","unstructured":"Jimenez-Saenz M, Martinez-Sanchez C. Green tea extracts and acute liver failure: the need for caution in their use and diagnostic assessment. Liver Transpl. 2007;13(7):1067.","journal-title":"Liver Transpl"},{"issue":"4","key":"781_CR159","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.freeradbiomed.2005.09.014","volume":"40","author":"G Galati","year":"2006","unstructured":"Galati G, et al. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med. 2006;40(4):570\u201380.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"781_CR160","doi-asserted-by":"publisher","first-page":"68","DOI":"10.7326\/0003-4819-144-1-200601030-00020","volume":"144","author":"HL Bonkovsky","year":"2006","unstructured":"Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med. 2006;144(1):68\u201371.","journal-title":"Ann Intern Med"},{"issue":"9","key":"781_CR161","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0210-5705(03)70527-5","volume":"27","author":"S Garcia-Moran","year":"2004","unstructured":"Garcia-Moran S, et al. Acute hepatitis associated with camellia thea and orthosiphon stamineus ingestion. Gastroenterol Hepatol. 2004;27(9):559\u201360.","journal-title":"Gastroenterol Hepatol"},{"key":"781_CR162","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","volume":"65","author":"G Mazzanti","year":"2009","unstructured":"Mazzanti G, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331\u201341.","journal-title":"Eur J Clin Pharmacol"},{"key":"781_CR163","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s10529-015-1926-x","volume":"37","author":"Y Cai","year":"2015","unstructured":"Cai Y, et al. High doses of (\u2013)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice. Biotechnol Lett. 2015;37:2371\u20137.","journal-title":"Biotechnol Lett"},{"issue":"2","key":"781_CR164","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.foodres.2013.01.038","volume":"53","author":"M da Silva Pinto","year":"2013","unstructured":"da Silva Pinto M. Tea: A new perspective on health benefits. Food Res Int. 2013;53(2):558\u201367.","journal-title":"Food Res Int"},{"key":"781_CR165","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biopha.2015.12.013","volume":"78","author":"A Chowdhury","year":"2016","unstructured":"Chowdhury A, et al. Protective role of epigallocatechin-3-gallate in health and disease: A perspective. Biomed Pharmacother. 2016;78:50\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"781_CR166","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jnutbio.2013.10.002","volume":"25","author":"S Wang","year":"2014","unstructured":"Wang S, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25(4):363\u201376.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"781_CR167","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/10010065","volume":"10","author":"F Delie","year":"2005","unstructured":"Delie F, Blanco-Pr\u00edeto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules. 2005;10(1):65\u201380.","journal-title":"Molecules"},{"issue":"1","key":"781_CR168","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms23010131","volume":"23","author":"P Paluszkiewicz","year":"2021","unstructured":"Paluszkiewicz P, et al. The application of nanoparticles in diagnosis and treatment of kidney diseases. Int J Mol Sci. 2021;23(1):131.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"781_CR169","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1582-4934.2002.tb00450.x","volume":"6","author":"M Voinea","year":"2002","unstructured":"Voinea M, Simionescu M. Designing of \u2018intelligent\u2019liposomes for efficient delivery of drugs. J Cell Mol Med. 2002;6(4):465\u201374.","journal-title":"J Cell Mol Med"},{"issue":"18","key":"781_CR170","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1039\/c2cc17295j","volume":"48","author":"B Hu","year":"2012","unstructured":"Hu B, et al. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides\/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun (Camb). 2012;48(18):2421\u20133.","journal-title":"Chem Commun (Camb)"},{"key":"781_CR171","doi-asserted-by":"publisher","first-page":"p5813793","DOI":"10.1155\/2017\/5813793","volume":"2017","author":"A Granja","year":"2017","unstructured":"Granja A, et al. Therapeutic potential of Epigallocatechin gallate nanodelivery systems. Biomed Res Int. 2017;2017:p5813793.","journal-title":"Biomed Res Int"},{"issue":"6","key":"781_CR172","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/bdd.617","volume":"29","author":"NC Alemdaroglu","year":"2008","unstructured":"Alemdaroglu NC, et al. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos. 2008;29(6):335\u201348.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"781_CR173","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41598-018-20174-x","volume":"8","author":"ACL Hachul","year":"2018","unstructured":"Hachul ACL, et al. Effect of the consumption of green tea extract during pregnancy and lactation on metabolism of mothers and 28d-old offspring. Sci Rep. 2018;8(1):1869.","journal-title":"Sci Rep"},{"issue":"3","key":"781_CR174","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ajcn\/73.3.607","volume":"73","author":"S Samman","year":"2001","unstructured":"Samman S, et al. Green tea or Rosemary extract added to foods reduces nonheme-iron absorption. Am J Clin Nutr. 2001;73(3):607\u201312.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"781_CR175","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/ccr3.707","volume":"4","author":"FS Fan","year":"2016","unstructured":"Fan FS. Iron deficiency anemia due to excessive green tea drinking. Clin Case Rep. 2016;4(11):1053.","journal-title":"Clin Case Rep"},{"issue":"10","key":"781_CR176","doi-asserted-by":"publisher","first-page":"443","DOI":"10.17221\/31\/2018-VETMED","volume":"63","author":"L Bartosikova","year":"2018","unstructured":"Bartosikova L, Necas J. Epigallocatechin gallate: A review. Veterin\u00e1rn\u00ed Medic\u00edna. 2018;63(10):443\u201367.","journal-title":"Veterin\u00e1rn\u00ed Medic\u00edna"},{"key":"781_CR177","unstructured":"Fujiki H, et al. Innovative strategy of cancer treatment with the combination of green tea catechins and anticancer compounds. Canc Cell Microenviron. 2015;2(4)."},{"issue":"6","key":"781_CR178","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.clnu.2013.03.008","volume":"32","author":"E Lecumberri","year":"2013","unstructured":"Lecumberri E, et al. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr. 2013;32(6):894\u2013903.","journal-title":"Clin Nutr"},{"issue":"5","key":"781_CR179","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/bph.12009","volume":"168","author":"J Steinmann","year":"2013","unstructured":"Steinmann J, et al. Anti-infective properties of epigallocatechin\u20103\u2010gallate (EGCG), a component of green tea. Br J Pharmacol. 2013;168(5):1059\u201373.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"781_CR180","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/molecules25030467","volume":"25","author":"M Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad M, et al. Preclinical activities of Epigallocatechin gallate in signaling pathways in cancer. Molecules. 2020;25(3):467.","journal-title":"Molecules"},{"issue":"3","key":"781_CR181","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2183\/pjab.87.66","volume":"87","author":"H Tachibana","year":"2011","unstructured":"Tachibana H. Green tea polyphenol sensing. Proc Japan Acad Ser B. 2011;87(3):66\u201380.","journal-title":"Proc Japan Acad Ser B"},{"key":"781_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-824X-5-9","volume":"5","author":"J-W Gu","year":"2013","unstructured":"Gu J-W, et al. A major green teA Catechin suppresses breast tumor angiogenesis and growth viA inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression. Vascular Cell. 2013;5:1\u201310.","journal-title":"Vascular Cell"},{"issue":"11","key":"781_CR183","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jnutbio.2013.06.003","volume":"24","author":"PVA Babu","year":"2013","unstructured":"Babu PVA, Liu D, Gilbert ER. Recent advances in Understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 2013;24(11):1777\u201389.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"781_CR184","doi-asserted-by":"publisher","first-page":"e87161","DOI":"10.1371\/journal.pone.0087161","volume":"9","author":"J Zhou","year":"2014","unstructured":"Zhou J, et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS ONE. 2014;9(1):e87161.","journal-title":"PLoS ONE"},{"issue":"3","key":"781_CR185","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/acm.2005.11.521","volume":"11","author":"R Cooper","year":"2005","unstructured":"Cooper R, Morr\u00e9 DJ, Morr\u00e9 DM. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J Altern Complement Med. 2005;11(3):521\u20138.","journal-title":"J Altern Complement Med"},{"issue":"7","key":"781_CR186","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.nutres.2009.06.008","volume":"29","author":"CL Shen","year":"2009","unstructured":"Shen CL, et al. Green tea and bone metabolism. Nutr Res. 2009;29(7):437\u201356.","journal-title":"Nutr Res"},{"issue":"12","key":"781_CR187","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/molecules27123909","volume":"27","author":"T Zhao","year":"2022","unstructured":"Zhao T, et al. Green tea (Camellia sinensis): A review of its phytochemistry, pharmacology, and toxicology. Molecules. 2022;27(12):3909.","journal-title":"Molecules"},{"issue":"7","key":"781_CR188","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2012.96863","volume":"309","author":"KD Vickery","year":"2013","unstructured":"Vickery KD, Sauser K, Davis MM. Policy responses to demand for health care access: from the individual to the population. JAMA. 2013;309(7):665\u20136.","journal-title":"JAMA"},{"issue":"2","key":"781_CR189","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5539\/jfr.v1n2p281","volume":"1","author":"A Yashin","year":"2012","unstructured":"Yashin A, Nemzer B, Yashin Y. Bioavailability of tea components. J Food Res. 2012;1(2):281.","journal-title":"J Food Res"},{"key":"781_CR190","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.redox.2013.12.022","volume":"2","author":"H-S Kim","year":"2014","unstructured":"Kim H-S, Quon MJ, Kim J-a. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, Epigallocatechin 3-gallate. Redox Biol. 2014;2:187\u201395.","journal-title":"Redox Biol"},{"issue":"1","key":"781_CR191","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2119\/2004-00032.Aneja","volume":"10","author":"R Aneja","year":"2004","unstructured":"Aneja R, et al. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004;10(1):55\u201362.","journal-title":"Mol Med"},{"issue":"8","key":"781_CR192","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s11255-015-1030-0","volume":"47","author":"J Lv","year":"2015","unstructured":"Lv J, et al. Protective effect of Epigallocatechin gallate, a major constituent of green tea, against renal ischemia\u2013reperfusion injury in rats. Int Urol Nephrol. 2015;47(8):1429\u201335.","journal-title":"Int Urol Nephrol"},{"key":"781_CR193","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2007.05.029","volume":"1159","author":"B Zhang","year":"2007","unstructured":"Zhang B, et al. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia\/reperfusion. Brain Res. 2007;1159:40\u201353.","journal-title":"Brain Res"},{"issue":"7","key":"781_CR194","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jpedsurg.2012.01.069","volume":"47","author":"A Sugiyama","year":"2012","unstructured":"Sugiyama A, et al. Beneficial effects of (\u2013)-epigallocatechin gallate on ischemia-reperfusion testicular injury in rats. J Pediatr Surg. 2012;47(7):1427\u201332.","journal-title":"J Pediatr Surg"},{"issue":"8","key":"781_CR195","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s11064-015-1647-5","volume":"40","author":"F Zhang","year":"2015","unstructured":"Zhang F, et al. Neuroprotective effects of (\u2013)-Epigallocatechin-3-Gallate against focal cerebral ischemia\/reperfusion injury in rats through Attenuation of inflammation. Neurochem Res. 2015;40(8):1691\u20138.","journal-title":"Neurochem Res"},{"issue":"5","key":"781_CR196","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4196\/kjpp.2011.15.5.259","volume":"15","author":"CS Piao","year":"2011","unstructured":"Piao CS, et al. The protective effect of Epigallocatechin-3 gallate on ischemia\/reperfusion injury in isolated rat hearts: an ex vivo approach. Korean J Physiol Pharmacol. 2011;15(5):259\u201366.","journal-title":"Korean J Physiol Pharmacol"},{"key":"781_CR197","doi-asserted-by":"crossref","unstructured":"Hu T, et al. Epigallocatechin-3-gallate confers protection against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis, apoptosis, and autophagy via modulation of 14-3-3\u03b7. Biomed Pharmacother. 2024;174:116542.","DOI":"10.1016\/j.biopha.2024.116542"},{"issue":"1","key":"781_CR198","doi-asserted-by":"publisher","first-page":"16809","DOI":"10.1038\/s41598-024-67867-0","volume":"14","author":"X Jia","year":"2024","unstructured":"Jia X, et al. Epigallocatechin gallate attenuated high glucose-induced pancreatic beta cell dysfunction by modulating DRP1-mediated mitochondrial apoptosis pathways. Sci Rep. 2024;14(1):16809.","journal-title":"Sci Rep"},{"key":"781_CR199","doi-asserted-by":"crossref","unstructured":"Khandia R, et al. A Comprehensive review of autophagy and its various roles in infectious, non-Infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells. 2019;8(7).","DOI":"10.3390\/cells8070674"},{"issue":"1","key":"781_CR200","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s11658-025-00713-x","volume":"30","author":"L Tang","year":"2025","unstructured":"Tang L, et al. Autophagy: a double-edged sword in ischemia-reperfusion injury. Cell Mol Biol Lett. 2025;30(1):42.","journal-title":"Cell Mol Biol Lett"},{"key":"781_CR201","doi-asserted-by":"publisher","first-page":"p6721530","DOI":"10.1155\/2018\/6721530","volume":"2018","author":"M Holczer","year":"2018","unstructured":"Holczer M, et al. Epigallocatechin-3-gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress. Oxid Med Cell Longev. 2018;2018:p6721530.","journal-title":"Oxid Med Cell Longev"},{"key":"781_CR202","doi-asserted-by":"crossref","unstructured":"Sari NWS, Tallei TE, Kolondam BJ. Benefits of green tea polyphenols for kidney health: a literature review. Grimsa J Sci Eng Technol. 2023.","DOI":"10.61975\/gjset.v1i2.13"},{"key":"781_CR203","doi-asserted-by":"crossref","unstructured":"Ferenczyov\u00e1 K, et al. Pharmacology of catechins in ischemia-reperfusion injury of the heart. Antioxid (Basel). 2021;10(9).","DOI":"10.3390\/antiox10091390"},{"issue":"2","key":"781_CR204","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3892\/ijmm.2017.3014","volume":"40","author":"Y Wu","year":"2017","unstructured":"Wu Y, et al. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia\/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. Int J Mol Med. 2017;40(2):389\u201399.","journal-title":"Int J Mol Med"},{"issue":"7","key":"781_CR205","doi-asserted-by":"publisher","first-page":"e70472","DOI":"10.1002\/fsn3.70472","volume":"13","author":"K A\u011fan","year":"2025","unstructured":"A\u011fan K, et al. Protective mechanisms of EGCG in mitigating oxidative stress and liver toxicity from cigarette Smoke-Induced damage. Food Sci Nutr. 2025;13(7):e70472.","journal-title":"Food Sci Nutr"},{"issue":"13","key":"781_CR206","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/foods14132193","volume":"14","author":"F Dav\u00ec","year":"2025","unstructured":"Dav\u00ec F, et al. Nutraceutical strategies for targeting mitochondrial dysfunction in neurodegenerative diseases. Foods. 2025;14(13):2193.","journal-title":"Foods"},{"key":"781_CR207","doi-asserted-by":"publisher","first-page":"896751","DOI":"10.1155\/2012\/896751","volume":"2012","author":"J Kang","year":"2012","unstructured":"Kang J, Pervaiz S. Mitochondria: redox metabolism and dysfunction. Biochem Res Int. 2012;2012:896751.","journal-title":"Biochem Res Int"},{"key":"781_CR208","doi-asserted-by":"crossref","unstructured":"Chen B, et al. A comprehensive review on beneficial effects of catechins on secondary mitochondrial diseases. Int J Mol Sci. 2022;23(19).","DOI":"10.3390\/ijms231911569"},{"issue":"6","key":"781_CR209","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00395-013-0392-7","volume":"108","author":"F Tullio","year":"2013","unstructured":"Tullio F, et al. Redox balance and cardioprotection. Basic Res Cardiol. 2013;108(6):392.","journal-title":"Basic Res Cardiol"},{"key":"781_CR210","doi-asserted-by":"crossref","unstructured":"Casanova E et al. Epigallocatechin gallate modulates muscle homeostasis in type 2 diabetes and obesity by targeting energetic and redox pathways: a narrative review. Int J Mol Sci. 2019;20(3).","DOI":"10.3390\/ijms20030532"},{"issue":"5","key":"781_CR211","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1089\/ars.2011.4459","volume":"18","author":"C Penna","year":"2013","unstructured":"Penna C, Perrelli MG, Pagliaro P. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. Antioxid Redox Signal. 2013;18(5):556\u201399.","journal-title":"Antioxid Redox Signal"},{"key":"781_CR212","first-page":"2759","volume-title":"Cerebral protection of Epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK Inhibition in a rat resuscitation model","author":"S Qin","year":"2019","unstructured":"Qin S, et al. Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK Inhibition in a rat resuscitation model. Development and Therapy: Drug Design. 2019:2759\u201368."},{"issue":"1","key":"781_CR213","first-page":"7824684","volume":"2019","author":"B Fu","year":"2019","unstructured":"Fu B, et al. Epicatechin gallate protects HBMVECs from ischemia\/reperfusion injury through ameliorating apoptosis and autophagy and promoting neovascularization. Oxidative Med Cell Longev. 2019;2019(1):7824684.","journal-title":"Oxidative Med Cell Longev"},{"key":"781_CR214","doi-asserted-by":"crossref","unstructured":"Wang L, et al. EGCG protects the mouse brain against cerebral ischemia\/reperfusion injury by suppressing autophagy via the akt\/ampk\/mtor phosphorylation pathway. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.921394"},{"issue":"8","key":"781_CR215","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s12272-013-0309-x","volume":"37","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, et al. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia\u2013reperfusion injuries through activation of RISK survival pathways in rats. Arch Pharm Res. 2014;37(8):1079\u201385.","journal-title":"Arch Pharm Res"},{"issue":"5","key":"781_CR216","first-page":"259","volume":"15","author":"CS Piao","year":"2011","unstructured":"Piao CS, et al. The protective effect of Epigallocatechin-3 gallate on ischemia\/reperfusion injury in isolated rat hearts: an ex vivo approach. Kjpp. 2011;15(5):259\u201366.","journal-title":"Kjpp"},{"issue":"4","key":"781_CR217","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4097\/kjae.2012.63.4.340","volume":"63","author":"SK Lee","year":"2012","unstructured":"Lee SK, et al. Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study. Korean J Anesthesiol. 2012;63(4):340\u20135.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"781_CR218","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/ijms19020628","volume":"19","author":"A Salameh","year":"2018","unstructured":"Salameh A, et al. Epigallocatechin gallate reduces ischemia\/reperfusion injury in isolated perfused rabbit hearts. Int J Mol Sci. 2018;19(2):628.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"781_CR219","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1096\/fj.04-1716fje","volume":"18","author":"PA Townsend","year":"2004","unstructured":"Townsend PA, et al. Epigallocatechin-3\u2010gallate inhibits STAT\u20101 activation and protects cardiac myocytes from ischemia\/reperfusion\u2010induced apoptosis. FASEB J. 2004;18(13):1621\u20133.","journal-title":"FASEB J"},{"issue":"5","key":"781_CR220","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3892\/mmr.2017.7515","volume":"16","author":"CY Qin","year":"2017","unstructured":"Qin CY, et al. Mitochondrial DNA\u2013induced inflammatory damage contributes to myocardial ischemia reperfusion injury in rats: cardioprotective role of epigallocatechin. Mol Med Rep. 2017;16(5):7569\u201376.","journal-title":"Mol Med Rep"},{"key":"781_CR221","doi-asserted-by":"crossref","unstructured":"Jang YH, et al. Polyphenol (-)-epigallocatechin gallate protection from ischemia\/reperfusion-induced renal injury in normotensive and hypertensive rats. Transplant Proceed. 2006;38(7):2190\u201394.","DOI":"10.1016\/j.transproceed.2006.06.101"},{"issue":"1","key":"781_CR222","first-page":"57","volume":"7","author":"C Aslan","year":"2014","unstructured":"Aslan C, et al. Effect of Epigallocatechin gallate on ischemia-reperfusion injury: an experimental study in a rat epigastric Island flap. Int J Clin Exp Med. 2014;7(1):57\u201366.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"781_CR223","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2012.03.013","volume":"420","author":"M Al-Maghrebi","year":"2012","unstructured":"Al-Maghrebi M, Renno WM, Al-Ajmi N. Epigallocatechin-3-gallate inhibits apoptosis and protects testicular seminiferous tubules from ischemia\/reperfusion-induced inflammation. Biochem Biophys Res Commun. 2012;420(2):434\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"781_CR224","doi-asserted-by":"crossref","unstructured":"Li Q, et al. Involvement of non\u2013coding RNAs in the pathogenesis of myocardial ischemia\/reperfusion injury (Review). Int J Mol Med. 2021;47(4).","DOI":"10.3892\/ijmm.2021.4875"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00781-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00781-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00781-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:03:16Z","timestamp":1757048596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00781-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":224,"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00781-y","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}